Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antenatal magnesium sulphate for neuroprotection in women at risk of preterm delivery at 28-36 weeks
PACTR202404671084461Recruiting
- Sponsor
- Dr Linda James Audu
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of magnesium sulfate in preterm birth and encephalopathy of prematurity (EoP) (2 arms), sponsored by Dr Linda James Audu. Primary endpoints: Perinatal death and Intraventricular haemorrhage. Started Jul 2023; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
preterm birthencephalopathy of prematurity (EoP)
Beyond the preview
Go deeper on PACTR202404671084461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202404671084461.